Share Price and Basic Stock Data
Last Updated: January 28, 2026, 9:20 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Puravankara Ltd operates in the construction and contracting industry, with its shares currently priced at ₹229 and a market capitalization of ₹5,447 Cr. The company has demonstrated fluctuating sales over recent quarters, with reported figures of ₹239 Cr in Sep 2022, rising to ₹574 Cr by Dec 2023. However, sales dipped to ₹323 Cr in Jun 2023 before recovering to ₹368 Cr in Sep 2023. The revenue trajectory is expected to continue evolving, with the latest quarterly data suggesting a strong rebound as the company recorded ₹920 Cr in Mar 2024. In FY 2024, Puravankara reported total sales of ₹2,185 Cr, a significant recovery from ₹1,236 Cr in FY 2023. This is indicative of the company’s potential to capitalize on the recovering real estate market in India, aligning with the broader sector’s growth trends. However, the variability in quarterly sales could suggest challenges in maintaining consistent demand or operational efficiency.
Profitability and Efficiency Metrics
Puravankara’s profitability metrics reveal significant volatility, with a reported net profit of -₹292 Cr for FY 2025, down from a profit of ₹67 Cr in FY 2023. The operating profit margin (OPM) stood at 14% for FY 2025, a decline from 19% in FY 2023, reflecting increased operational pressures. The company recorded a negative profit before tax in the latest fiscal year, which indicates challenges in managing expenses, as total expenses rose to ₹1,723 Cr in FY 2025 from ₹1,006 Cr in FY 2023. The interest coverage ratio (ICR) is concerning at 0.66x, suggesting that earnings are insufficient to cover interest obligations, which could lead to liquidity issues. Furthermore, the return on equity (ROE) is reported at 10.0%, which is relatively moderate compared to industry standards, indicating that shareholder returns are not optimal. The company must enhance operational efficiency to improve profitability and manage costs better, especially in a competitive market environment.
Balance Sheet Strength and Financial Ratios
Puravankara’s balance sheet reflects increasing leverage, with total borrowings rising to ₹4,497 Cr as of Sep 2025, up from ₹2,944 Cr in FY 2023. This increase in debt is concerning given the company’s negative net profit and its implications for financial stability. The company’s current ratio stands at 1.05x, slightly above the typical threshold of 1.0, indicating that it can cover short-term liabilities but may struggle if liquidity pressures increase. The price-to-book value ratio is recorded at 3.38x, suggesting that the market values the company at a premium relative to its net assets. However, this high valuation must be justified by future performance improvements. The return on capital employed (ROCE) is reported at 6.04%, which is below the industry average, indicating that capital is not being utilized effectively to generate returns. Overall, while there are some strengths in asset management, the rising debt levels pose risks to financial health.
Shareholding Pattern and Investor Confidence
As of Sep 2025, the shareholding pattern of Puravankara shows a strong promoter holding of 75%, which reflects confidence from the founding stakeholders in the company’s long-term prospects. Foreign Institutional Investors (FIIs) account for 17.23% of the holdings, indicating a moderate level of foreign interest, while Domestic Institutional Investors (DIIs) hold a mere 0.49%. The public shareholding stands at 7.28%, which is relatively low and may suggest limited retail investor interest. The number of shareholders has decreased from 38,157 in Dec 2022 to 42,246 as of Sep 2025, showing some fluctuation in investor participation. This pattern may affect the liquidity of the stock, as a concentrated shareholder base can lead to price volatility. The high promoter stake and increasing FII presence could be seen as a positive sign, but the low DII and public participation may raise questions about broader market confidence.
Outlook, Risks, and Final Insight
The outlook for Puravankara Ltd hinges on several key factors, including market conditions in the real estate sector, operational efficiency improvements, and debt management. The company faces risks from rising borrowing costs due to elevated interest rates, which could further strain profitability given the current ICR of 0.66x. Additionally, fluctuations in quarterly sales and profitability metrics raise concerns about operational resilience. If the company can successfully navigate these challenges and leverage its strong promoter backing, there is potential for recovery and growth in shareholder value. However, the ongoing volatility in financial performance and the need for strategic operational adjustments remain critical for sustaining investor confidence and achieving long-term success. Ultimately, the company’s ability to manage its debt and improve profitability will be pivotal in determining its market position in the competitive construction industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Techindia Nirman Ltd | 20.1 Cr. | 14.0 | 27.1/13.8 | 7.54 | 0.00 % | 0.70 % | 7.32 % | 10.0 | |
| Tarmat Ltd | 123 Cr. | 49.5 | 73.6/45.0 | 40.0 | 72.9 | 0.00 % | 1.55 % | 0.92 % | 10.0 |
| Supreme Infrastructure India Ltd | 210 Cr. | 83.8 | 133/79.2 | 133 | 0.00 % | % | % | 10.0 | |
| SPML Infra Ltd – a Multi-sector Infrastructure Player | 1,322 Cr. | 171 | 323/136 | 26.9 | 112 | 0.00 % | 8.91 % | 7.78 % | 2.00 |
| SKIL Infrastructure Ltd | 28.8 Cr. | 1.33 | 4.15/1.05 | 3.24 | 8.93 | 0.00 % | 1.10 % | 4.76 % | 10.0 |
| Industry Average | 5,933.29 Cr | 188.80 | 39.68 | 108.04 | 0.05% | 6.53% | 9.16% | 7.10 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 239 | 392 | 389 | 323 | 368 | 574 | 920 | 658 | 496 | 318 | 542 | 524 | 644 |
| Expenses | 195 | 283 | 373 | 260 | 283 | 378 | 808 | 528 | 384 | 302 | 511 | 458 | 540 |
| Operating Profit | 45 | 110 | 16 | 63 | 85 | 196 | 112 | 130 | 112 | 16 | 30 | 67 | 104 |
| OPM % | 19% | 28% | 4% | 19% | 23% | 34% | 12% | 20% | 23% | 5% | 6% | 13% | 16% |
| Other Income | 13 | 18 | 91 | 13 | 13 | 22 | 27 | 18 | 32 | 17 | 22 | 14 | 19 |
| Interest | 76 | 94 | 102 | 98 | 105 | 105 | 127 | 119 | 141 | 143 | 152 | 161 | 169 |
| Depreciation | 4 | 5 | 4 | 5 | 6 | 7 | 10 | 7 | 8 | 8 | 11 | 10 | 11 |
| Profit before tax | -22 | 29 | 1 | -28 | -13 | 106 | 3 | 22 | -5 | -118 | -111 | -90 | -57 |
| Tax % | -22% | 22% | -2,093% | -36% | -13% | 27% | 352% | 31% | 257% | -22% | -21% | -24% | -24% |
| Net Profit | -17 | 23 | 27 | -18 | -11 | 78 | -7 | 15 | -17 | -93 | -88 | -69 | -43 |
| EPS in Rs | -0.72 | 0.95 | 1.12 | -0.75 | -0.47 | 3.29 | -0.28 | 0.64 | -0.71 | -3.90 | -3.62 | -2.85 | -1.76 |
Last Updated: December 29, 2025, 11:35 am
Below is a detailed analysis of the quarterly data for Puravankara Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 644.00 Cr.. The value appears strong and on an upward trend. It has increased from 524.00 Cr. (Jun 2025) to 644.00 Cr., marking an increase of 120.00 Cr..
- For Expenses, as of Sep 2025, the value is 540.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 458.00 Cr. (Jun 2025) to 540.00 Cr., marking an increase of 82.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 104.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Jun 2025) to 104.00 Cr., marking an increase of 37.00 Cr..
- For OPM %, as of Sep 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 13.00% (Jun 2025) to 16.00%, marking an increase of 3.00%.
- For Other Income, as of Sep 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Jun 2025) to 19.00 Cr., marking an increase of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 169.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 161.00 Cr. (Jun 2025) to 169.00 Cr., marking an increase of 8.00 Cr..
- For Depreciation, as of Sep 2025, the value is 11.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.00 Cr. (Jun 2025) to 11.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -57.00 Cr.. The value appears strong and on an upward trend. It has increased from -90.00 Cr. (Jun 2025) to -57.00 Cr., marking an increase of 33.00 Cr..
- For Tax %, as of Sep 2025, the value is -24.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded -24.00%.
- For Net Profit, as of Sep 2025, the value is -43.00 Cr.. The value appears strong and on an upward trend. It has increased from -69.00 Cr. (Jun 2025) to -43.00 Cr., marking an increase of 26.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -1.76. The value appears strong and on an upward trend. It has increased from -2.85 (Jun 2025) to -1.76, marking an increase of 1.09.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,310 | 1,672 | 1,584 | 1,407 | 1,415 | 2,050 | 2,128 | 963 | 955 | 1,236 | 2,185 | 2,014 | 2,028 |
| Expenses | 835 | 1,287 | 1,244 | 998 | 1,110 | 1,612 | 1,681 | 681 | 746 | 1,006 | 1,730 | 1,723 | 1,811 |
| Operating Profit | 476 | 386 | 340 | 409 | 305 | 439 | 447 | 282 | 208 | 230 | 456 | 291 | 217 |
| OPM % | 36% | 23% | 21% | 29% | 22% | 21% | 21% | 29% | 22% | 19% | 21% | 14% | 11% |
| Other Income | 18 | 18 | 47 | 68 | 90 | 76 | 59 | 93 | 427 | 203 | 75 | 86 | 72 |
| Interest | 241 | 233 | 243 | 290 | 251 | 328 | 343 | 357 | 332 | 360 | 434 | 555 | 624 |
| Depreciation | 8 | 15 | 16 | 16 | 15 | 15 | 23 | 20 | 18 | 17 | 28 | 35 | 40 |
| Profit before tax | 244 | 156 | 128 | 171 | 129 | 172 | 140 | -2 | 286 | 55 | 68 | -212 | -376 |
| Tax % | 35% | 15% | 34% | 25% | 29% | 33% | 37% | 82% | 48% | -20% | 38% | -14% | |
| Net Profit | 160 | 133 | 83 | 129 | 91 | 114 | 88 | -4 | 148 | 67 | 42 | -183 | -292 |
| EPS in Rs | 6.75 | 5.60 | 3.49 | 5.44 | 3.85 | 4.82 | 3.73 | -0.17 | 6.22 | 2.80 | 1.78 | -7.59 | -12.13 |
| Dividend Payout % | 28% | 28% | 22% | 41% | 42% | 21% | 0% | 0% | 80% | 36% | 354% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -16.88% | -37.59% | 55.42% | -29.46% | 25.27% | -22.81% | -104.55% | 3800.00% | -54.73% | -37.31% | -535.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -20.72% | 93.02% | -84.88% | 54.73% | -48.08% | -81.74% | 3904.55% | -3854.73% | 17.42% | -498.40% |
Puravankara Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -1% |
| 3 Years: | 28% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -450% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 45% |
| 3 Years: | 39% |
| 1 Year: | -36% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 1% |
| 3 Years: | -1% |
| Last Year: | -10% |
Last Updated: September 5, 2025, 12:45 pm
Balance Sheet
Last Updated: December 4, 2025, 1:51 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 |
| Reserves | 2,055 | 2,142 | 2,165 | 2,248 | 2,275 | 1,738 | 1,795 | 1,777 | 1,923 | 1,868 | 1,765 | 1,612 | 1,500 |
| Borrowings | 1,697 | 1,793 | 2,172 | 2,067 | 2,379 | 2,895 | 2,670 | 2,835 | 2,627 | 2,944 | 3,325 | 4,332 | 4,497 |
| Other Liabilities | 869 | 1,109 | 1,090 | 1,814 | 2,011 | 3,973 | 3,487 | 3,697 | 3,955 | 5,125 | 6,518 | 8,169 | 9,219 |
| Total Liabilities | 4,739 | 5,163 | 5,546 | 6,247 | 6,783 | 8,725 | 8,071 | 8,429 | 8,623 | 10,055 | 11,727 | 14,232 | 15,335 |
| Fixed Assets | 92 | 112 | 88 | 114 | 125 | 128 | 122 | 111 | 96 | 107 | 163 | 232 | 233 |
| CWIP | 0 | 12 | 0 | 0 | 36 | 42 | 9 | 0 | 3 | 1 | 2 | 0 | 0 |
| Investments | 91 | 69 | 525 | 116 | 131 | 130 | 132 | 138 | 82 | 104 | 36 | 40 | 47 |
| Other Assets | 4,556 | 4,970 | 4,932 | 6,017 | 6,491 | 8,424 | 7,807 | 8,179 | 8,442 | 9,844 | 11,526 | 13,960 | 15,055 |
| Total Assets | 4,739 | 5,163 | 5,546 | 6,247 | 6,783 | 8,725 | 8,071 | 8,429 | 8,623 | 10,055 | 11,727 | 14,232 | 15,335 |
Below is a detailed analysis of the balance sheet data for Puravankara Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 119.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 119.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,612.00 Cr. (Mar 2025) to 1,500.00 Cr., marking a decrease of 112.00 Cr..
- For Borrowings, as of Sep 2025, the value is 4,497.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 4,332.00 Cr. (Mar 2025) to 4,497.00 Cr., marking an increase of 165.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 9,219.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,169.00 Cr. (Mar 2025) to 9,219.00 Cr., marking an increase of 1,050.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 15,335.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14,232.00 Cr. (Mar 2025) to 15,335.00 Cr., marking an increase of 1,103.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 233.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Mar 2025) to 233.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 7.00 Cr..
- For Other Assets, as of Sep 2025, the value is 15,055.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,960.00 Cr. (Mar 2025) to 15,055.00 Cr., marking an increase of 1,095.00 Cr..
- For Total Assets, as of Sep 2025, the value is 15,335.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,232.00 Cr. (Mar 2025) to 15,335.00 Cr., marking an increase of 1,103.00 Cr..
However, the Borrowings (4,497.00 Cr.) are higher than the Reserves (1,500.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 475.00 | 385.00 | 338.00 | 407.00 | 303.00 | 437.00 | 445.00 | 280.00 | 206.00 | 228.00 | 453.00 | 287.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 96 | 78 | 100 | 71 | 45 | 51 | 116 | 93 | 157 | 83 | 84 |
| Inventory Days | 1,328 | 1,718 | 6,990 | 3,052 | 2,438 | |||||||
| Days Payable | 145 | 155 | 658 | 211 | 216 | |||||||
| Cash Conversion Cycle | 96 | 1,279 | 1,641 | 100 | 6,403 | 2,886 | 2,273 | 116 | 93 | 157 | 83 | 84 |
| Working Capital Days | 425 | 372 | 536 | 502 | 410 | 180 | 153 | 488 | 580 | 322 | 32 | -27 |
| ROCE % | 13% | 9% | 9% | 10% | 8% | 10% | 10% | 8% | 13% | 7% | 10% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -7.59 | 1.78 | 2.80 | 6.22 | -0.20 |
| Diluted EPS (Rs.) | -7.52 | 1.77 | 2.80 | 6.22 | -0.20 |
| Cash EPS (Rs.) | -6.50 | 3.25 | 2.21 | 7.18 | 0.76 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 72.98 | 79.67 | 84.05 | 86.38 | 80.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 72.98 | 79.67 | 84.05 | 86.38 | 80.49 |
| Revenue From Operations / Share (Rs.) | 84.91 | 92.14 | 52.11 | 40.26 | 40.51 |
| PBDIT / Share (Rs.) | 15.62 | 22.67 | 16.91 | 27.00 | 15.89 |
| PBIT / Share (Rs.) | 14.15 | 21.49 | 16.18 | 26.26 | 15.03 |
| PBT / Share (Rs.) | -9.21 | 3.18 | 1.02 | 12.27 | -0.01 |
| Net Profit / Share (Rs.) | -7.97 | 2.07 | 1.48 | 6.44 | -0.09 |
| NP After MI And SOA / Share (Rs.) | -7.58 | 1.78 | 2.80 | 6.22 | -0.19 |
| PBDIT Margin (%) | 18.39 | 24.60 | 32.44 | 67.08 | 39.22 |
| PBIT Margin (%) | 16.66 | 23.31 | 31.05 | 65.23 | 37.10 |
| PBT Margin (%) | -10.85 | 3.44 | 1.95 | 30.47 | -0.04 |
| Net Profit Margin (%) | -9.39 | 2.24 | 2.84 | 15.99 | -0.22 |
| NP After MI And SOA Margin (%) | -8.93 | 1.93 | 5.37 | 15.46 | -0.48 |
| Return on Networth / Equity (%) | -10.39 | 2.24 | 3.34 | 7.22 | -0.24 |
| Return on Capital Employeed (%) | 17.58 | 20.30 | 15.44 | 23.32 | 14.21 |
| Return On Assets (%) | -1.26 | 0.36 | 0.66 | 1.71 | -0.05 |
| Long Term Debt / Equity (X) | 0.06 | 0.30 | 0.23 | 0.28 | 0.28 |
| Total Debt / Equity (X) | 2.48 | 1.74 | 1.47 | 1.28 | 0.74 |
| Asset Turnover Ratio (%) | 0.15 | 0.20 | 0.13 | 0.10 | 0.08 |
| Current Ratio (X) | 1.05 | 1.12 | 1.19 | 1.30 | 1.24 |
| Quick Ratio (X) | 0.18 | 0.20 | 0.18 | 0.15 | 0.16 |
| Inventory Turnover Ratio (X) | 0.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 353.52 | 178.36 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 212.48 | 141.82 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | -253.52 | -78.36 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | -112.48 | -41.82 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.66 | 1.24 | 1.11 | 1.93 | 1.06 |
| Interest Coverage Ratio (Post Tax) (X) | 0.65 | 1.11 | 1.10 | 1.46 | 0.99 |
| Enterprise Value (Cr.) | 9425.39 | 7334.08 | 4121.77 | 4843.19 | 2925.63 |
| EV / Net Operating Revenue (X) | 4.68 | 3.36 | 3.34 | 5.07 | 3.05 |
| EV / EBITDA (X) | 25.44 | 13.64 | 10.28 | 7.56 | 7.76 |
| MarketCap / Net Operating Revenue (X) | 2.91 | 2.28 | 1.25 | 2.65 | 1.74 |
| Retention Ratios (%) | 0.00 | -253.52 | -78.36 | 0.00 | 0.00 |
| Price / BV (X) | 3.38 | 2.64 | 0.77 | 1.24 | 0.87 |
| Price / Net Operating Revenue (X) | 2.91 | 2.28 | 1.25 | 2.65 | 1.74 |
| EarningsYield | -0.03 | 0.01 | 0.04 | 0.05 | 0.00 |
After reviewing the key financial ratios for Puravankara Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -7.59. This value is below the healthy minimum of 5. It has decreased from 1.78 (Mar 24) to -7.59, marking a decrease of 9.37.
- For Diluted EPS (Rs.), as of Mar 25, the value is -7.52. This value is below the healthy minimum of 5. It has decreased from 1.77 (Mar 24) to -7.52, marking a decrease of 9.29.
- For Cash EPS (Rs.), as of Mar 25, the value is -6.50. This value is below the healthy minimum of 3. It has decreased from 3.25 (Mar 24) to -6.50, marking a decrease of 9.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 72.98. It has decreased from 79.67 (Mar 24) to 72.98, marking a decrease of 6.69.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 72.98. It has decreased from 79.67 (Mar 24) to 72.98, marking a decrease of 6.69.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 84.91. It has decreased from 92.14 (Mar 24) to 84.91, marking a decrease of 7.23.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 15.62. This value is within the healthy range. It has decreased from 22.67 (Mar 24) to 15.62, marking a decrease of 7.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.15. This value is within the healthy range. It has decreased from 21.49 (Mar 24) to 14.15, marking a decrease of 7.34.
- For PBT / Share (Rs.), as of Mar 25, the value is -9.21. This value is below the healthy minimum of 0. It has decreased from 3.18 (Mar 24) to -9.21, marking a decrease of 12.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -7.97. This value is below the healthy minimum of 2. It has decreased from 2.07 (Mar 24) to -7.97, marking a decrease of 10.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -7.58. This value is below the healthy minimum of 2. It has decreased from 1.78 (Mar 24) to -7.58, marking a decrease of 9.36.
- For PBDIT Margin (%), as of Mar 25, the value is 18.39. This value is within the healthy range. It has decreased from 24.60 (Mar 24) to 18.39, marking a decrease of 6.21.
- For PBIT Margin (%), as of Mar 25, the value is 16.66. This value is within the healthy range. It has decreased from 23.31 (Mar 24) to 16.66, marking a decrease of 6.65.
- For PBT Margin (%), as of Mar 25, the value is -10.85. This value is below the healthy minimum of 10. It has decreased from 3.44 (Mar 24) to -10.85, marking a decrease of 14.29.
- For Net Profit Margin (%), as of Mar 25, the value is -9.39. This value is below the healthy minimum of 5. It has decreased from 2.24 (Mar 24) to -9.39, marking a decrease of 11.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -8.93. This value is below the healthy minimum of 8. It has decreased from 1.93 (Mar 24) to -8.93, marking a decrease of 10.86.
- For Return on Networth / Equity (%), as of Mar 25, the value is -10.39. This value is below the healthy minimum of 15. It has decreased from 2.24 (Mar 24) to -10.39, marking a decrease of 12.63.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.58. This value is within the healthy range. It has decreased from 20.30 (Mar 24) to 17.58, marking a decrease of 2.72.
- For Return On Assets (%), as of Mar 25, the value is -1.26. This value is below the healthy minimum of 5. It has decreased from 0.36 (Mar 24) to -1.26, marking a decrease of 1.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.30 (Mar 24) to 0.06, marking a decrease of 0.24.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.48. This value exceeds the healthy maximum of 1. It has increased from 1.74 (Mar 24) to 2.48, marking an increase of 0.74.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.15. It has decreased from 0.20 (Mar 24) to 0.15, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 1.5. It has decreased from 1.12 (Mar 24) to 1.05, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 1. It has decreased from 0.20 (Mar 24) to 0.18, marking a decrease of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.21, marking an increase of 0.21.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 353.52 (Mar 24) to 0.00, marking a decrease of 353.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 212.48 (Mar 24) to 0.00, marking a decrease of 212.48.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -253.52 (Mar 24) to 0.00, marking an increase of 253.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -112.48 (Mar 24) to 0.00, marking an increase of 112.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 3. It has decreased from 1.24 (Mar 24) to 0.66, marking a decrease of 0.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 3. It has decreased from 1.11 (Mar 24) to 0.65, marking a decrease of 0.46.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,425.39. It has increased from 7,334.08 (Mar 24) to 9,425.39, marking an increase of 2,091.31.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.68. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 4.68, marking an increase of 1.32.
- For EV / EBITDA (X), as of Mar 25, the value is 25.44. This value exceeds the healthy maximum of 15. It has increased from 13.64 (Mar 24) to 25.44, marking an increase of 11.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.91, marking an increase of 0.63.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has increased from -253.52 (Mar 24) to 0.00, marking an increase of 253.52.
- For Price / BV (X), as of Mar 25, the value is 3.38. This value exceeds the healthy maximum of 3. It has increased from 2.64 (Mar 24) to 3.38, marking an increase of 0.74.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.91, marking an increase of 0.63.
- For EarningsYield, as of Mar 25, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.03, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Puravankara Ltd:
- Net Profit Margin: -9.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.58% (Industry Average ROCE: 6.53%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -10.39% (Industry Average ROE: 9.16%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.18
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 39.68)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -9.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Realty | No.130/1, Ulsoor Road, Bengaluru Karnataka 560042 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Puravankara | Chairman |
| Mr. Ashish Ravi Puravankara | Managing Director |
| Ms. Amanda Joy Puravankara | Whole Time Director |
| Mr. Anup Shah Sanmukh | Independent Director |
| Prof. Shailaja Jha | Independent Director |
| Mr. K G Krishnamurthy | Independent Director |
FAQ
What is the intrinsic value of Puravankara Ltd?
Puravankara Ltd's intrinsic value (as of 28 January 2026) is ₹46.22 which is 79.55% lower the current market price of ₹226.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹5,360 Cr. market cap, FY2025-2026 high/low of ₹339/205, reserves of ₹1,500 Cr, and liabilities of ₹15,335 Cr.
What is the Market Cap of Puravankara Ltd?
The Market Cap of Puravankara Ltd is 5,360 Cr..
What is the current Stock Price of Puravankara Ltd as on 28 January 2026?
The current stock price of Puravankara Ltd as on 28 January 2026 is ₹226.
What is the High / Low of Puravankara Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Puravankara Ltd stocks is ₹339/205.
What is the Stock P/E of Puravankara Ltd?
The Stock P/E of Puravankara Ltd is .
What is the Book Value of Puravankara Ltd?
The Book Value of Puravankara Ltd is 68.3.
What is the Dividend Yield of Puravankara Ltd?
The Dividend Yield of Puravankara Ltd is 0.00 %.
What is the ROCE of Puravankara Ltd?
The ROCE of Puravankara Ltd is 6.04 %.
What is the ROE of Puravankara Ltd?
The ROE of Puravankara Ltd is 10.0 %.
What is the Face Value of Puravankara Ltd?
The Face Value of Puravankara Ltd is 5.00.